Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $38.3700 (-2.02%) ($38.3700 - $38.3700) on Fri. Sep. 8, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.11% (three month average) | RSI | 20 | Latest Price | $38.3700(-2.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -2% a day on average for past five trading days. | Weekly Trend | HALO declines -2.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) QQQ(77%) XBI(64%) IGOV(61%) XLF(49%) XRT(49%) | Factors Impacting HALO price | HALO will decline at least -1.055% in a week (0% probabilities). INDA(-44%) VXX(-40%) TBT(-26%) LIT(-23%) UUP(-19%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.055% (StdDev 2.11%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $34.77(-9.38%) | Resistance Level | $42.23 | 5 Day Moving Average | $40.46(-5.17%) | 10 Day Moving Average | $41.5(-7.54%) | 20 Day Moving Average | $42.23(-9.14%) | To recent high | -12.9% | To recent low | 13.8% | Market Cap | $5.244b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |